13 April 2006

Contents

Treatment alerts

• Important renal safety information regarding the use of tenofovir and Truvada

Conference reports

• Further reports from 13th Conference on Retroviruses and Opportunistic Infections (CROI), 5-8 February 2006, Denver

• Pharmacokinetics of antiretrovirals in pregnancy: tenofovir, nelfinavir, lopinavir/r

• Risk of central nervous system birth defects associated with ART exposure during pregnancy

• No increase in adverse pregnancy outcomes in Thai women receiving nevirapine-containing HAART

• ARV treatment following singe dose nevirapine exposure

• Association of HIV replication capacity with mother to child transmission

• Association between HIV subtype and detection of K103N

Pipeline report

• HIV/HCV coinfection: re-treating hepatitis C in people coinfected with HIV